ReviewPharmaceutics2025
Marine Macroalgae in Topical Formulations: Bioactive Compounds, Variability, Analytical Challenges and Skin Benefits.
Review in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Antioxidant and Cytoprotective Effects of Chilean Macroalgae Against Oxidative Stress-Induced Damage in Gastric Epithelial Cells.Nutrients · 2026Article
- Algae-Derived Bioactive Compounds as Platforms for Translational Biotechnology and Health Applications.Biotech (Basel (Switzerland)) · 2026Review
- Marine Bioactives in Liver Aging: Mechanistic Insights and Translational Potential.Marine drugs · 2026Review
- The DiatomAntioxidants (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Marine macroalgae, classified into three major groups, brown (Phaeophyceae), red (Rhodophyta), and green (Chlorophyta), represent a source of structurally diverse compounds relevant for topical applications. This narrative review of the peer-reviewed literature and regulatory databases targets macroalgae-derived active ingredients in cosmetic formulations and in wound-healing applications. It outlines major compound classes (polyphenols, sulfated polysaccharides, carotenoids, fatty acids, and peptides), along with their documented biological effects on skin (antioxidant, anti-inflammatory, moisturizing, photoprotective, and anti-aging activity) and regulatory/safety aspects with formulation strategies. This review also addresses the variability in compound concentrations resulting from species, environmental conditions, and seasonal factors, which impacts reproducibility and standardization. Common extraction techniques like solvent extraction, ultrasound-assisted extraction, supercritical fluid extraction, and enzyme-assisted methods are described in relation to compound class and yield. Analytical methods used for the identification and quantification of these compounds, including HPLC, GC-MS, and FTIR, are then summarized. Additionally, recent in vitro and in vivo studies evaluating the bioactivity and safety of macroalgae-derived ingredients are discussed. This review compiles relevant evidence to inform formulation strategies and ingredient evaluation in the context of marine-based topical products.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.